Bydureon Bcise OverviewExenatide, sold under the brand name Byetta and Bydureon among others, is a medication used to treat diabetes mellitus type 2. It is used together with diet, exercise, and potentially other antidiabetic medication. It is a less preferred treatment option after metformin and sulfonylureas. It is given by injection under the skin within an hour before the first and last meal of the day. A once-weekly injection version i...
Read more Bydureon Bcise Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Byetta
Recent Bydureon Bcise Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- For Suspension, Extended Release: 2mg, 2mg/vial
- Injection: 2mg, 300mcg/1.2ml (250mcg/ml), 300ugm/1.2ml (250ugm/ml), 300ugm/1.2ml(250ugm/ml), 600mcg/2.4ml (250mcg/ml), 600ugm/2.4ml (250ugm/ml), 600ugm/2.4ml(250ugm/ml)
- Suspension, Extended Release: 2mg/0.85ml (2mg/0.85ml)
NDC Database Records for Bydureon Bcise: (1 result)Sorted by National Drug Code
- 0310-6540 Bydureon Bcise 2 mg/.85ml Subcutaneous Injection, Suspension, Extended Release by Astrazeneca Pharmaceuticals Lp